162 related articles for article (PubMed ID: 16302325)
1. An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne.
Cunliffe WJ; Fernandez C; Bojar R; Kanis R; West F;
J Dermatolog Treat; 2005; 16(4):213-8. PubMed ID: 16302325
[TBL] [Abstract][Full Text] [Related]
2. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
[TBL] [Abstract][Full Text] [Related]
3. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Kellett N; West F; Finlay AY
Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
[TBL] [Abstract][Full Text] [Related]
4. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
[TBL] [Abstract][Full Text] [Related]
5. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
[TBL] [Abstract][Full Text] [Related]
6. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S
Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881
[TBL] [Abstract][Full Text] [Related]
7. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ; Holland KT; Bojar R; Levy SF
Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
[TBL] [Abstract][Full Text] [Related]
9. Clinical assessment of topical erythromycin gel with and without zinc acetate for treating mild-to-moderate acne vulgaris.
Sayyafan MS; Ramzi M; Salmanpour R
J Dermatolog Treat; 2020 Nov; 31(7):730-733. PubMed ID: 30998422
[No Abstract] [Full Text] [Related]
10. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
Langner A; Sheehan-Dare R; Layton A
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
[TBL] [Abstract][Full Text] [Related]
11. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
12. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
Schaller M; Sebastian M; Ress C; Seidel D; Hennig M
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):966-73. PubMed ID: 26915831
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Dhawan SS
Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
[TBL] [Abstract][Full Text] [Related]
14. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
17. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris.
Shalita AR; Smith JG; Parish LC; Sofman MS; Chalker DK
Int J Dermatol; 1995 Jun; 34(6):434-7. PubMed ID: 7657446
[TBL] [Abstract][Full Text] [Related]
18. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
Warner GT; Plosker GL
Am J Clin Dermatol; 2002; 3(5):349-60. PubMed ID: 12069641
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
[TBL] [Abstract][Full Text] [Related]
20. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
Kuhlman DS; Callen JP
Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]